| NDC Code | 63323-881-16 |
|---|
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-881-16) > 15 mL in 1 VIAL, SINGLE-DOSE (63323-881-01) |
|---|
| Product NDC | 63323-881 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Sodium Phosphates |
|---|
| Non-Proprietary Name | Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20220330 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA209997 |
|---|
| Manufacturer | Fresenius Kabi USA, LLC |
|---|
| Substance Name | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
|---|
| Strength | 142; 276 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
|---|